Consonance Capital Management LP Compass Therapeutics, Inc. Transaction History

Consonance Capital Management LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$1.43 - $3.1 $2.71 Million - $5.88 Million	-1,896,211 Reduced 54.18%	1,603,789 $4.22 Million
Q4 2021 Feb 14, 2022	BUY	$2.88 - $3.98 $10.1 Million - $13.9 Million	3,500,000 New	3,500,000 $11.2 Million

92M

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $161M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.